Skip to main content

Table 1 Versican immunohistochemistry evaluation in mammary carcinomas in benign mixed tumours in female dogs

From: Versican expression in canine carcinomas in benign mixed tumours: is there an association with clinical pathological factors, invasion and overall survival?

Areas

Parameters

All

Score

Group 1 (n = 25)

Group 2 (n = 24)

P value

In situ

Intensity

49

1

6/25

1/24

0.0002

   

2

15/25

5/24

 
   

3

4/25

14/24

 
   

4

0/25

4/24

 
 

Percentage of the tissue section stained positive (mean)

49

 

43.24

68.96

 
 

Intensity

49

1

1/25

0/24

<0.0001

   

2

1/25

0/24

 
   

3

17/25

0/24

 
   

4

6/25

24/24

 
 

Percentage of the tissue section stained positive (mean)

49

 

67.6

88.96

 

P value

   

<0.0001

<0.0001

 
  1. Group 1, represented by cases with low versican expression; and Group 2, represented by cases with versican overexpression.
  2. Wilcoxon Test.